Start | Browse by Day | Author Index | Keyword Index

H4 Update on 13-Valent Pneumococcal Conjugate Vaccine (PCV13)

Presenters in this workshop will discuss the ACIP’s recommendation for use of recently licensed 13-valent pneumococcal conjugate vaccine and provide guidance for for providers regarding transition from PCV7 to PCV13.
Wednesday, April 21, 2010: 11:00 AM-12:00 PM
International Ballroom South
Moderator:
Pekka Nuorti
11:20 AM
Introductory Remarks
11:00 AM
ACIP Recommendations for Use of PCV13
Pekka Nuorti, MD, DSc, Medical Epidemiologist, Centers for Disease Control and Prevention
Slides
11:25 AM
PCV13 Program Implementation—Guidance for Providers Regarding Transition From PCV7 to PCV13
Abigail Shefer, MD, MPH, Associate Director for Science, Centers for Disease Control and Prevention
Audio File Slides Recorded presentation
11:45 AM
Discussion
See more of: Submissions
<< Previous Workshop | Next Workshop >>